T A Gaziano

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi The global cardiovascular diseases risk pattern in a peri-urban working-class community in South Africa. The Mamre study
    Krisela Steyn
    Chronic Diseases of Lifestyle Unit, Medical Research Council, P O Box 19070, Tygerberg 7505, South Africa
    Ethn Dis 14:233-42. 2004
  2. ncbi Scaling up chronic disease prevention interventions in lower- and middle-income countries
    Thomas A Gaziano
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Annu Rev Public Health 34:317-35. 2013
  3. ncbi Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis
    Joshua Schulman-Marcus
    1Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
    BMC Cardiovasc Disord 10:13. 2010
  4. ncbi The global cost of nonoptimal blood pressure
    Thomas A Gaziano
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Hypertens 27:1472-7. 2009
  5. ncbi Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort
    Thomas A Gaziano
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Lancet 371:923-31. 2008
  6. ncbi Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa
    T A Gaziano
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Heart 94:140-4. 2008
  7. ncbi Scaling up interventions for chronic disease prevention: the evidence
    Thomas A Gaziano
    Harvard Medical School, Boston, MA, USA
    Lancet 370:1939-46. 2007
  8. ncbi Reducing the growing burden of cardiovascular disease in the developing world
    Thomas A Gaziano
    Division of Cardiology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:13-24. 2007
  9. ncbi Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
    Thomas A Gaziano
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Lancet 368:679-86. 2006
  10. ncbi Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level
    Thomas A Gaziano
    Division of Social Medicine and Health Inequalities, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Circulation 112:3569-76. 2005

Research Grants

  1. Global Cardiovascular Disease Policy Model for Screening Prevention and Treatment
    Thomas A Gaziano; Fiscal Year: 2010

Detail Information

Publications16

  1. ncbi The global cardiovascular diseases risk pattern in a peri-urban working-class community in South Africa. The Mamre study
    Krisela Steyn
    Chronic Diseases of Lifestyle Unit, Medical Research Council, P O Box 19070, Tygerberg 7505, South Africa
    Ethn Dis 14:233-42. 2004
    ..Such variables could possibly be used for global CVD risk calculations, instead of depending on biochemical estimates for these calculations...
  2. ncbi Scaling up chronic disease prevention interventions in lower- and middle-income countries
    Thomas A Gaziano
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Annu Rev Public Health 34:317-35. 2013
    ..Continued discussion of proven cost-effective interventions for chronic diseases in the developing world will be useful for improving public health policy...
  3. ncbi Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis
    Joshua Schulman-Marcus
    1Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
    BMC Cardiovasc Disord 10:13. 2010
    ..Use of ECG could reduce pre-hospital delay among patients who first present to a general practitioner (GP). We assessed whether performing ECG on patients with acute chest pain would improve long-term outcomes and be cost-effective...
  4. ncbi The global cost of nonoptimal blood pressure
    Thomas A Gaziano
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Hypertens 27:1472-7. 2009
    ..However, no exhaustive study has been done to evaluate its potential costs, globally. We, therefore, set out to estimate the global economic cost of nonoptimal blood pressure...
  5. ncbi Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort
    Thomas A Gaziano
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Lancet 371:923-31. 2008
    ....
  6. ncbi Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa
    T A Gaziano
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Heart 94:140-4. 2008
    ..It further outlines many of the areas where we know less and must focus our future research in trying to outline cost-effective solutions...
  7. ncbi Scaling up interventions for chronic disease prevention: the evidence
    Thomas A Gaziano
    Harvard Medical School, Boston, MA, USA
    Lancet 370:1939-46. 2007
    ..Finally, we review evidence for policy implementation in areas of strong causality or highly probable benefit--eg, changes in personal interventions for diabetes reduction, restructuring of health systems, and wider policy decisions...
  8. ncbi Reducing the growing burden of cardiovascular disease in the developing world
    Thomas A Gaziano
    Division of Cardiology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:13-24. 2007
    ..Despite the burden, cost-effective strategies exist at the population and individual levels for reducing CVD. Integral to all personal intervention strategies is an adequate assessment of the underlying risk of disease...
  9. ncbi Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
    Thomas A Gaziano
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Lancet 368:679-86. 2006
    ..We therefore aimed to establish whether use of evidence-based multidrug regimens for patients at high risk for cardiovascular disease would be cost-effective in low-income and middle-income countries...
  10. ncbi Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level
    Thomas A Gaziano
    Division of Social Medicine and Health Inequalities, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Circulation 112:3569-76. 2005
    ..Guidelines based on blood pressure level for initiation of treatment of hypertension may be too costly compared with an approach based on absolute cardiovascular disease (CVD) risk, especially in developing countries...
  11. ncbi Cardiovascular disease in the developing world and its cost-effective management
    Thomas A Gaziano
    Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, USA
    Circulation 112:3547-53. 2005
  12. ncbi The South African Hypertension Guideline 2006 is evidence-based but not cost-effective
    Thomas A Gaziano
    Divisions of Cardiovascular Medicine, and Social Medicine and Health Inequalities, Brigham and Women's Hospital, Boston, MA, USA
    S Afr Med J 96:1170-3. 2006
  13. ncbi The Framingham Heart Study's impact on global risk assessment
    Asaf Bitton
    Division of General Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Prog Cardiovasc Dis 53:68-78. 2010
    ..New studies and risk scores inspired by the Framingham Heart Study need to simplify risk scoring in developing countries so that affordable prevention strategies can be implemented...
  14. ncbi Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort
    J M Gaziano
    Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215 1204, USA
    J Am Coll Cardiol 35:96-105. 2000
    ..This study examined the relationship between light-to-moderate alcohol consumption and cause-specific mortality...
  15. ncbi Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs
    Stephen S Lim
    Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA 98102, USA
    Lancet 370:2054-62. 2007
    ..43 to $0.90 across low-income countries and from $0.54 to $2.93 across middle-income countries. This package could effectively meet three-quarters of the proposed global goal with a moderate increase in health expenditure...
  16. ncbi Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option
    James Irlam
    Indian J Pediatr 75:86; author reply 86-7. 2008

Research Grants1

  1. Global Cardiovascular Disease Policy Model for Screening Prevention and Treatment
    Thomas A Gaziano; Fiscal Year: 2010
    ..It will incorporate the sensitivity, specificity, costs, and benefits of screening, and the costs and benefits of early intervention. ..